Recovery of infectious human parainfluenza virus type 3 from cDNA

Virology

Volumn 235, Issue 2, 1997, Pages 323-332

  Durbin, Anna P ^a   Hall, Susan L ^a   Siew, Jeffrey W ^a   Whitehead, Stephen S ^a   Collins, Peter L ^a   Murphy, Brian R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GENOME; NONHUMAN; PARAINFLUENZA VIRUS 3; POINT MUTATION; PRIORITY JOURNAL; VIRUS CULTURE;

ANIMALIA; CRICETINAE; HUMAN PARAINFLUENZA VIRUS 3; VACCINIA; VACCINIA VIRUS;

EID: 0030763320     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8697     Document Type: Article

References (32)

1. Baron M. D., Barrett T. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71:1997;1265-1271.
2. Belshe R. B., Hissom F. K. Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers. J. Med. Virol. 10:1982;235-242.
3. Collins P. L., Chanock R. M., McIntosh K. Parainfluenza viruses. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 1205-1243.
4. Collins P. L., Hill M. G., Camargo E., Grosfeld H., Chanock R. M., Murphy B. R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
5. Conzelmann K. Genetic manipulation of non-segmented negative strand RNA viruses. J. Gen. Virol. 77:1996;381-389.
6. Dimock K., Collins P. L. Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3. J. Virol. 67:1993;2772-2778.
7. Durbin A. P., Siew J. W., Murphy B. R., Collins P. L. Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology. 1997.
8. Galinski M. S. Paramyxoviridae: Transcription and replication. Adv. Virus Res. 39:1991;129-162.
9. Galinski M. S., Mink M. A., Pons M. W. Molecular cloning and sequence analysis of the human parainfluenza 3 virus gene encoding the L protein. Virology. 165:1988;499-510.
10. Garcin D., Pelet T., Calain P., Roux L., Curran J., Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus. EMBO J. 14:1995;6087-6094.
11. Hall S. L., Stokes A., Tierney E. L., London W. T., Belshe R. B., Newman F. C., Murphy B. R. Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys. Virus Res. 22:1992;173-184.
12. Karron R. A., Makhene M., Gay K., Wilson M. H., Clements M. L., Murphy B. R. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. Pediatr. Infect. Dis. J. 15:1996;650-654.
13. Karron R. A., Wright P. F., Hall S. L., Makhene M., Thompson J., Burns B. A., Tollefson S., Steinhoff M. C., Wilson M. H., Harris D. O., Clements M. L., Murphy B. R. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J. Infect. Dis. 171:1995a;1107-1114.
14. Karron R. A., Wright P. F., Newman F. K., Makhene M., Thompson J., Samorodin R., Wilson M. H., Anderson E. L., Clements M. L., Murphy B. R., Belshe R. B. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J. Infect. Dis. 172:1995b;1445-1450.
15. Kato A., Sakai Y., Shioda T., Kondo T., Nakanishi M., Nagai Y. Initation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells. 1:1996;569-579.
16. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:1987;367-382.
17. Lawson N. D., Stillman E. A., Whitt M. A., Rose J. K. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA. 92:1995;4477-4481.
18. Murphy B. R., Prince G. A., Collins P. L., Van Wyke Coelingh K., Olmsted R. A., Spriggs M. K., Parrott R. H., Kim H. W., Brandt C. D., Chanock R. M. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. Virus Res. 11:1988;1-15.
19. Murphy B. R., Sotnikov A. V., Lawrence L. A., Banks S. M., Prince G. A. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine. 8:1990;497-502.
20. Palese P., Zheng H., Engelhardt O. G., Pleschka S., Garcia-Sastre A. Negative-strand RNA viruses: Genetic engineering and applications. Proc. Natl. Acad. Sci. USA. 93:1996;11354-11358.
21. Perrotta A. T., Been M. D. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature. 350:1991;434-436.
22. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dotsch C., Christiansen G., Billeter M. A. Rescue of measles viruses from cloned DNA. EMBO J. 14:1995;5773-5784.
23. Reed G., Jewett P. H., Thompson J., Tollefson S., Wright P. F. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J. Infect. Dis. 175:1997;807-813.
24. Schnell M. J., Mebatsion T., Conzelmann K. K. Infectious rabies viruses from cloned cDNA. EMBO J. 13:1994;4195-4203.
25. Spriggs M. K., Collins P. L. Sequence analysis of the P and C protein genes of human parainfluenza virus type 3: Patterns of amino acid sequence homology among paramyxovirus proteins. J. Gen. Virol. 67:1986;2705-2719.
26. Stokes A., Tierney E. L., Murphy B. R., Hall S. L. The complete nucleotide sequence of the JS strain of human parainfluenza virus type 3: Comparison with the Wash/47885/57 prototype strain. Virus Res. 25:1992;91-103.
27. Stokes A., Tierney E. L., Sarris C. M., Murphy B. R., Hall S. L. The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3). Virus Res. 30:1993;43-52.
28. van Wyke Coelingh K. L., Winter C., Murphy B. R. Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus. Virology. 143:1985;569-582.
29. van Wyke Coelingh K. L., Winter C. C., Jorgensen E. D., Murphy B. R. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: Sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. J. Virol. 61:1987;1473-1477.
30. van Wyke Coelingh K. L., Winter C. C., Tierney E. L., London W. T., Murphy B. R. Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge. J. Infect. Dis. 157:1988;655-662.
31. Whelan S. P., Ball L. A., Barr J. N., Wertz G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA. 92:1995;8388-8392.
32. Wyatt L. S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology. 210:1995;202-205.